Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
Aravinthan LoganathanNarainraj KamalarajCarlos El-HaddadKevin PilePublished in: International journal of rheumatic diseases (2021)
The prevalence of MetS is significantly increased in PsA populations compared with PsO and RA populations. Further studies should be performed using a standardized definition of MetS in PsA, RA, and PsO populations to determine whether addressing the metabolic components in MetS offers any therapeutic benefits and in terms of attaining MDA and improving cardiovascular health.
Keyphrases
- rheumatoid arthritis
- prostate cancer
- metabolic syndrome
- disease activity
- risk factors
- genetic diversity
- ankylosing spondylitis
- interstitial lung disease
- insulin resistance
- systemic lupus erythematosus
- cardiovascular disease
- adipose tissue
- breast cancer cells
- cell death
- cell proliferation
- skeletal muscle
- signaling pathway
- uric acid
- cell cycle arrest